Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27

CD27 Signaling Increases the Frequency of Regulatory T Cells and Promotes Tumor Growth

(2012) C. Claus et al.   CANCER RESEARCH

CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression

(2012) Christian Schürch et al.   JOURNAL OF CLINICAL INVESTIGATION

T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies

(2011) D. R. Shaffer et al.   BLOOD

Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15

(2011) Hideyuki Ishii et al.   INTERNATIONAL JOURNAL OF CANCER

Soluble CD27 induces IgG production through activation of antigen-primed B cells

(2011) L. V. P. Dang et al.   JOURNAL OF INTERNAL MEDICINE

Aggressive peripheral CD70-positive t-cell lymphoma associated with severe chronic active EBV infection

(2011) Donald R. Shaffer et al.   PEDIATRIC BLOOD & CANCER

Production of Interferon- -Inducible Protein-10 and Its Role as an Autocrine Invasion Factor in Nasal Natural Killer/T-Cell Lymphoma Cells

(2009) S. Moriai et al.   CLINICAL CANCER RESEARCH

CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia

(2008) A. W. Ho et al.   BLOOD

CD70 as a therapeutic target in human malignancies

(2008) Iqbal S Grewal   EXPERT OPINION ON THERAPEUTIC TARGETS